Transforming growth factor alpha (TGF-α) expression in biopsies of colorectal carcinoma is a significant prognostic indicator

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1999-2003

  Younes, Mamoun ^a,b   Fernandez, Lynn ^a   Lechago, Juan ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Colon cancer; Immunohistochemistry; Preoperative biopsy; Survival; TGF

Indexed keywords

MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR BIOPSY;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; BIOPSY; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0029783629     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Boring CC, Squires TS, Tong T: Cancer statistics, 1993. CA cancer J. Clin. 43: 7-26, 1993.
2. Greenwald P: Colon cancer overview. Cancer 70: 1206-1215, 1992.
3. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr: Recent cancer trends in the United States. J Natl Cancer Inst 87: 175-182, 1995
4. Cancer of the colon and rectum. Br J Surg 77: 1063-10655, 1990.
5. Lippman ME, Sorace RA, Bagley CS, Danforth DW, Lichter A, Wcsler MN: Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. Natl Cancer Inst Monogr 1: 153-159, 1986.
6. Stephens FO: Intraarterial induction chemotherapy in locally advanced stage III breast cancer. Cancer 66: 645-650,1990.
7. Schultz PK, Herr HW, Zhang Z-F, Bajorin DF, Seidman A, Sarkis A, Fair WR, Scherr D, Bosl GJ, Scher HI: Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol 12: 1394-1401, 1994.
8. Kane MJ: Adjuvant systemic treatment for carcinoma of the colon and rectum. Semin Oncol 18:421 -442, 1991.
9. Marks G, Mohiuddin NM, Masoni L, Pecchioli L: High dose preoperative radiation and full thickness local excision: a new option for patients with select cancers of the rectum. Dis Colon Rectum 33: 735-739,1990.
10. Kettlewell MG: Endoscopic transanal resection for rectal cancer. J Colorectal Dis 6: 82-83, 1991.
11. Agarwal N, Leighton L, Mandile MA, Cayten CG: Outcomes of surgery for colorectal cancer in patients age 80 years and older. Am J Gastroenterol 85: 1096-1101, 1990.
12. Derynck R: Transforming growth factor α. Cell 54: 593-595, 1988.
13. Lee GH, Merlino G, Fausto N: Development of liver tumors in transforming growth factor a transgenic mice. Cancer Res 52: 5162-170, 1992.
14. Kaufmann W K, Zhang Y, Kaufman DG: Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms. Carcinogenesis 13: 1481-1483, 1992.
15. Hsia CC, Axiotis CA, Di Bisceglie AM, Tabor E: Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 70: 1049-1056, 1992.
16. Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC: Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 13: 320-330, 1993.
17. Coffey RJ Jr, Shipley GD, Moses HL: Production of transforming growth factors by human colon cancer cell lines. Cancer Res 46: 1164-1169, 1986.
18. Cofley RJ Jr, Goustin AS, Soderquist AM, Shipley GD, Wolfshohl J, Carpenter G, Moses HL: Transforming growth factor α and ß expression in human colon cancer cell lines: implication for an autocrine model. Cancer Res 47: 4590-4594, 1987.
19. Anzano MA, Rieman D, Prichette W, Bowen-Pope DF, Greig R: Growth factor production by human colon carcinoma cell lines. Cancer Res 49: 2898-2904, 1989.
20. Untawale S, Zorbas MA, Hodgson CP, Coffey RJ, Gallick GE, North SM, Wildrick DM, Olive, M, Blick M, Yeoman LC, Boman BM: Transforming growth factor-a production in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene. Cancer Res 53: 1630-1636, 1993.
21. Karnes WE Jr, Walsh JH, Wu SV, Kim RS, Martin MG, Wong HC, Mendelsohn J, Park J-G, Cuttitta F: Autonomous proliferation of colon cancer cells that coexpress transforming growth factor α and its receptor. Variable effects of receptor-blocking antibody. Gastroenterology 102: 474-485,1992.
22. Ciardiello F, Bianco C, Normanno N, Baldassarre G, Pepe S, Tortora G, Bianco AR, Salomon DS: Infection with a transforming growth factor a anti-sense retroviral expression vector reduces the in vitro growth and transformation of human colon cancer cell line. Int J Cancer 54: 952-958, 1993.
23. Ziober BL, Willson JKV, Hymphrey LE, Childress-Fields K, Brattani MG: Autocrine transforming growth factor-α is associated with progression of transformed properties in human colon cancer cells. J Biol Chem 268: 691-698, 1993.
24. Markowitz SD, Molkentin K, Gerbic C, Jackson J, Stellato T, Willson JKV: Growth stimulation by coexpression of transforming growth factor-α and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. J Clin Invest 86: 356-362, 1990.
25. Liu D, Gagliardi G, Nasim MM, Alison MR, Oates T, Lalani H-N, Stamp GWH, Pignatelli M: TGF-α can act as morphogen and/or mitogen in a colon-cancer cell line. Int J Cancer 56: 603-608, 1994.
26. Celano P, Berchtold CM, Mabry M, Carroll M, Sidransky D, Casero RA Jr, Lupu R: Induction of markers of normal differentiation in human colon carcinoma cells by the vrasH oncogene. Cell Growth & Differ 4. 341 -347, 1993.